NuVasive, Inc.
NUVA
NUVA was delisted on the 31st of August, 2023.
261 hedge funds and large institutions have $3.61B invested in NuVasive, Inc. in 2021 Q1 according to their latest regulatory filings, with 37 funds opening new positions, 98 increasing their positions, 82 reducing their positions, and 52 closing their positions.
45% more call options, than puts
Call options by funds: $19.8M | Put options by funds: $13.6M
20% more capital invested
Capital invested by funds: $3.01B → $3.61B (+$601M)
20% more repeat investments, than reductions
Existing positions increased: 98 | Existing positions reduced: 82
7% less funds holding
Funds holding: 280 → 261 (-19)
29% less first-time investments, than exits
New positions opened: 37 | Existing positions closed: 52
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$80M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$62.2M |
| 3 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
+$60.9M |
| 4 |
PIM
Paradice Investment Management
Denver,
Colorado
|
+$55.9M |
| 5 |
Jennison Associates
New York
|
+$43.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$56.9M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$34.5M |
| 3 |
Norges Bank
Oslo,
Norway
|
-$33.2M |
| 4 |
DM
Deerfield Management
New York
|
-$31.8M |
| 5 |
HRCM
Hood River Capital Management
Palm Beach Gardens,
Florida
|
-$31.1M |
NUVA Hedge Fund Activity: Q1 2021 in Review
261 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in NuVasive, Inc. (NUVA) for Q1 2021, worth a combined $3.61B — up 20% from $3.01B a quarter earlier.
Sellers outnumbered buyers: 52 funds closed out of NUVA and 37 opened new positions — a net loss of 15 holders — while 82 trimmed existing stakes and 98 added.
The largest buyer was JP Morgan Chase, adding an estimated $80M. The largest seller was Citadel Advisors, cutting an estimated $56.9M.
- 261 institutional investors held NuVasive, Inc. (NUVA) as of Q1 2021, down from 280 in Q4 2020.
- Funds reported $3.61B of NuVasive, Inc. stock for Q1 2021, up 20% quarter-over-quarter.
- 37 funds opened new NuVasive, Inc. positions in Q1 2021 and 52 closed out, a net change of -15 holders.
- The largest NuVasive, Inc. buyer in Q1 2021 was JP Morgan Chase, an estimated $80M added.
- The largest NuVasive, Inc. seller in Q1 2021 was Citadel Advisors, an estimated $56.9M sold.
Based on aggregated 13F filings for Q1 2021.